BeyondtheModel
AI Rewrote How Regulatory Inspections are Completed. Has Your Playbook Kept Up?
The FDA now reads your submissions with AI. Your competitors run the same AI models you do. And when an output is wrong, the liability is still yours. “Beyond the Model” is ELIQUENT’s brief on AI in regulatory affairs, quality, and pharmacovigilance, drawing on a team with more than 350 combined years inside FDA and global health authorities to clarify what to change, what to protect, and where the advantage now sits.
In “Beyond the Model,” we discuss how to:
Optimize Your Filings for AI-Based Platforms
The first reader of your FDA submission may now be an AI-powered algorithm. When it can’t process content effectively, you lose time.
Redeploy Your Senior Experts to the Decisions AI Can’t Make
Generative AI is commoditizing drafting, literature review, and data extraction. The expert decisions that determine regulatory outcomes are only becoming more valuable.
Build an Infrastructure That Safeguards Against AI Errors
When an AI-assisted submission gets it wrong, accountability stays with the sponsor. Keep outputs defensible, and own your validation evidence to avoid setbacks when models change.
Understand the Data and Intelligence That AI Can’t Access
The intelligence that decides regulatory outcomes never gets published. Expert judgment, proprietary intelligence, and trusted relationships create value in an AI-enabled industry.
Bring Clarity and Competitive Advantage to AI Regulatory Workflows
In this brief we discuss:
- How AI-enabled models evaluate submissions and how to structure content that is evidence-traceable and built for AI-assisted review.
- Where AI assists and where expert judgment determines outcomes across regulatory affairs, quality & compliance, pharmacovigilance, medical writing, and beyond.
- What robust AI governance requires, from explainable outputs and validation documentation to monitoring for drift, bias, and hallucination.
- The seven-question diagnostic to better understand how your organization is building intelligence and how to improve practices to compound value across every engagement.
Get the AI in Life Sciences, Regulatory, Quality and Safety Brief Here:
Complete the form to access your copy of “Beyond the Model.”
(* Indicated fields are mandatory.)